Allied Biotech Corporation (TPEX:1780)

Taiwan · Delayed Price · Currency is TWD

23.60

-0.50 (-2.07%)

Oct 20, 2026, 1:30 PM CST

Market Cap	2.57B +53.2%
Revenue (ttm)	922.49M +14.7%
Net Income	180.52M +270.2%
EPS	1.86 +265.8%
Shares Out	109.08M
PE Ratio	12.72
Forward PE	n/a
Dividend	1.25 (5.30%)
Ex-Dividend Date	Jun 4, 2026

Volume	25,140
Open	24.00
Previous Close	24.10
Day's Range	23.60 - 24.00
52-Week Range	17.25 - 36.85
Beta	0.17
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 18, 2026

About Allied Biotech

Allied Biotech Corporation engages in the manufacture and sale of carotenoids worldwide. The company’s products include Beta-Carotene that offers yellow to reddish orange shades to appeal color in various applications; Beta-Apo-8'-Carotenal, which is used as a food colorant, and provides a range of orange to red shades; and Lycopene, which offers a range of red shades as a nutrient for food, dietary supplements, and pharmaceutical products. It also provides Canthaxanthin, which offers a range of shades of reddish orange for food and beverage ap... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2001

Employees 40

Stock Exchange Taipei Exchange

Ticker Symbol 1780

Full Company Profile

Financial Performance

In 2025, Allied Biotech's revenue was 849.51 million, an increase of 5.28% compared to the previous year's 806.92 million. Earnings were 129.46 million, an increase of 28.25%.

Financial Statements